Specialised nutrition and health divisions have helped to balance global food giants Nestlé and Danone after each reported a slowdown in sales across core areas of business as the impact of acquisitions, divestment's and ‘currency headwinds’ took...
Strong first-quarter growth for pharmaceutical and speciality ingredients player Lonza will pave the way for higher-than-expected sales growth in 2017, said the firm as it upgraded its full-year outlook.
One of the world’s biggest makers of nutritional ingredients, Royal DSM, saw pre-tax profits increase by 17% last year, with a strong performance from its nutrition division.
Better-than-expected first-half sales growth has allowed the world’s biggest food company, Nestlé, to confirm its 2015 outlook despite poor exchange rates leading to decreased profits.
Strong growth in health and nutrition, coupled with increasing demand for cultures and enzymes in Europe and the Americas has led Chr. Hansen to a ‘solid’ performance in Q1, says the firm.
Nestlé has cut its sales growth expectations for the full year – but even the revised target will be a stretch, according to the company’s financial chief.
Danish bioscience firm Chr. Hansen is raising its revenue predictions by 11-13 per cent for 2010/11 after what it describes as “strong growth” in its first quarter from the September 1, 2010 to the end of November.
Food ingredients company Danisco has reported “solid” growth during Q1 of 2010, with the continued recovery of its sweeteners division particularly notable.
Naturex is ready to implement the next step in its plan to make
more strategic acquisitions in the food and nutraceuticals sector
plan after raising €13.2m by issuing more than a quarter of a
million new shares.
